Intractable & Rare Diseases Research
Online ISSN : 2186-361X
Print ISSN : 2186-3644
ISSN-L : 2186-3644
Policy Forum
Access to orphan drugs in the Middle East: Challenge and perspective
Ziyad S. AlmalkiAbdullah K. AlahmariJeff J. GuoChristina M.L. Kelton
Author information

2012 Volume 1 Issue 4 Pages 139-143


An orphan drug is a drug developed specifically to treat a rare medical condition. With a combined population of less than 400 million, about 2.8 million patients are estimated to be suffering from a rare disease in the Middle East. Some disorders such as hemoglobinopathy, glucose-6-phosphate dehydrogenase deficiency, autosomal recessive syndromes, and several metabolic disorders have a presence throughout the Middle East. In order to promote the treatment of these diseases, Middle Eastern governments need to facilitate education and training of healthcare personnel; develop and execute a method for obtaining and paying for orphan drugs; and, finally, provide tax, marketing, and other incentives to domestic and international firms to develop drugs specifically for the diseases

Content from these authors
© 2012 International Research and Cooperation Association for Bio & Socio-Sciences Advancement
Next article